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Abstract
Background Recent evidence suggests that the use of
acellular dermal matrices in prosthetic breast reconstruc-
tion, revision, or augmentation may be associated with an
increased risk of complications. In this article we report our
results of a potential alternative, using a new long-term
resorbable synthetic matrix in these cases.
Methods A retrospective study was performed evaluating
11 primary breast reconstructions (19 breasts), 43 second-
ary reconstructions (77 breasts), 3 augmentation/augmen-
tation mastopexys (6 breasts), and 5 mastopexys (10
breasts) in 62 patients using TIGR Matrix Surgical Mesh.
Results Follow-up ranged from 9.4 to 26.1 months with
an average follow-up of 16.5 months. Average age was
54 years. The number of patients who had prior radiation
was 9 (14.5 %). Four patients (6.5 %) were smokers.
Postoperative breast complications included necrosis of two
flaps (1.8 %), two seromas requiring drainage (1.8 %), four
infection/extrusions (3.6 %), two relapses of inframammary
fold/malposition (1.8 %), and two with rippling (1.8 %).
Other complications included six cases of asymmetry that
required a corrective procedure. In a variety of breast sur-
gery cases very good aesthetic results were achieved.
Conclusion The long-term absorbable synthetic matrix,
TIGR Matrix Surgical Mesh, shows potential when used
as temporary reinforcement in patients undergoing breast
reconstruction or breast surgery revisions and in primary
aesthetic procedures, and it appears to be a viable alter-
native to the use of acellular dermal matrices.
Level of Evidence IV This journal requires that authors
assign a level of evidence to each article. For a full
description of these Evidence-Based Medicine ratings,
please refer to the Table of Contents or the online
Instructions to Authors http://www.springer.com/00266.
Keywords Absorbable synthetic surgical mesh  TIGR
Matrix Surgical Mesh  Long-term resorbable surgical
mesh  Acellular dermal matrix  Reconstructive breast
surgery  Tissue expander implant breast surgery
Introduction
The use of tissue expanders has become the most common
technique of performing breast reconstruction as evidenced by
the 2011 ASPS Plastic Surgery Statistics Report [2]. Chedo-
mir Radovan, MD, a great innovator of the 1970 s, is credited
with the development of the Radovan breast expander [31,
32]. He initially described placing tissue expanders in the
subcutaneous position. This technique evolved over time
leading to the placement of the expander in a submuscular
position. This approach to expander-based breast recon-
struction is used to maintain total muscle coverage in order to
protect the expander from the incision and potential exposure
[3]. This technique includes elevating the pectoralis major
muscle, serratus anterior muscle, and the anterior fascia of the
rectus abdominus muscle [4, 7]. The rigidity of the fascia
inferiorly restricts inferior pole expansion and often results in
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a high-riding implant. Furthermore, with complete muscle
coverage the inframammary fold is ill-defined [29, 30].
Complete muscle coverage was necessary when a more
extensive mastectomy was performed in order to protect the
implant from exposure beneath the large incision.
The advent of the skin-sparing mastectomy enabled the
muscle to be detached inferiorly where the lower skin flap
affords coverage to the implant. Although expansion is
facilitated with the release of the muscle inferiorly [34],
pectoral muscle retraction and bottoming out of the implant
became problems [22]. Therefore, the inferior edge of the
muscle was sutured to the fascia. However, sutures alone
were often ineffective in holding the muscle in position. The
tension often resulted in disruption as the sutures cut through
the tissues. Acellular dermal matrices (ADM) offered a
viable solution to this problem [9, 33, 35, 37]. The ADM
reinforces the muscle and also provides supplemental tissue
to the space between the released muscle and the infra-
mammary fold. It allows the pectoralis muscle to be released,
expands the space, allows fixation of the inframammary fold,
and fills in the tissue void between the inferior edge of the
pectoralis muscle and the inframammary fold. However, due
to recently reported problems encountered with ADM,
including seroma, infection, slow vascularization, disrup-
tion, reconstructive failure, patient concerns, and costs, we
looked at a new long-term resorbable synthetic mesh as a
potential alternative [10, 13, 17, 19, 40–43]. Surgical mesh
has multiple fixation points thus offering greater tissue fix-
ation compared to sutures. This mesh also functions as a
scaffold facilitating native tissue in-growth.
Initially, permanent synthetic meshes (PTFE and Ultr-
apro) were used but they proved to be too rigid. We then
resorted to absorbable mesh (Vicryl), which functioned well
for the first few months, but rapid absorption resulted in
bottoming out in certain cases. We therefore began using a
new synthetic long-term absorbable scaffold known as
TIGR Matrix Surgical Mesh (Novus Scientific Pte Ltd,
Singapore). Here we report on the use of this new long-term
resorbable synthetic mesh (TIGRMatrix) in over 50 breast
cases. The categories of breast surgery in this study include
primary reconstruction, reconstruction revision, augmenta-
tion/mastopexy revision, augmentation/augmentation mas-
topexy, and mastopexy. The aim of this study was not to
compare TIGR Matrix to ADMs or other similar products
but to look at this mesh as a potential alternative to ADMs in
a variety of breast surgery cases. We hypothesize that
TIGR Matrix is a viable alternative to ADMs.
Materials and Methods
A retrospective review was performed on patients who
underwent a primary or secondary breast reconstructive
surgical procedure as well as patients who underwent a
primary aesthetic procedure or aesthetic surgery revision
that included the use of TIGR Matrix Surgical Mesh
from 2011 to 2012. All patients meeting these criteria
were included. There were no exclusion criteria. All
cases were performed by a single surgeon in a private
practice setting. Informed verbal and written consent
were obtained in all cases. The principles outlined in
the Declaration of Helsinki were strictly followed. The
smooth Spectrum adjustable implant [5, 6, 8] or a smooth
silicone gel implant was used in all cases. Smooth
implants were used because our experience does not show
an increased frequency of capsular contracture associated
with their use. Also, they are easier to work with and
have been shown in our experience to have a lower
postoperative seroma rate. The adjustable implants were
used in all immediate reconstructions where there was a
concern about circulation, in patients who had prior
radiation, and in cases of excessive scarring. In patients
undergoing revision surgery where capsules were present,
either capsulectomy or aggressive capsular scoring was
performed in order to facilitate vascularization of the
mesh. Regular clinical follow-up was done in all patients.
Small biopsies of the mesh were taken for histological
analysis in patients who had to return to the operating
room.
Outpatient charts from this single private practice were
reviewed retrospectively. Data collected included patient
age, follow-up time, history of prior radiation, history of
smoking, reasons for surgery, procedures performed, peri-
operative findings, postoperative complications, and need
for postoperative interventions.
TIGR Matrix Surgical Mesh is a macroporous mesh
knitted from two different degradable fibers: a fast-
degrading fiber and a slow-degrading fiber. The fast-
degrading fiber is a copolymer between glycolide and tri-
methylene carbonate, and the slow-degrading fiber is
mainly a copolymer between lactide and trimethylene
carbonate. The materials used in TIGR Matrix are all
very well known from the suture industry and have been
used clinically since 1970 in a vast number of different
medical devices [27]. Both fibers degrade into small
molecules that are readily absorbed and excreted from the
body [20, 28, 39]. The fast-degrading fiber gives extra
support during the first wound-healing phase and is totally
resorbed within 4 months after implantation. About
2 weeks after implantation TIGR Matrix will gradually
become softer and more flexible due to the ongoing deg-
radation in the fast-degrading fiber, unlocking the knitting
pattern of the slow-degrading fiber. The slow-degrading
fibers keep their mechanics up to 6–9 months and are
completely resorbed after *3 years due to degradation by
hydrolysis [18].
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Results
A total of 62 patients (112 breasts) composed the study
population. The mean age of the patients at the time of
operation was 54 years. Average follow-up was
16.5 months (range 9.4–26.1). No patients were lost to
follow-up. Nine patients (14.5 %) had had prior radiation
and four patients (6.5 %) were active smokers (Table 1).
Reasons for surgery included capsular contraction, ele-
vation or reconstruction of the inframammary fold, implant
removal or replacement, asymmetric primary results, scar
revision, and implant repositioning. A total of 11 primary
reconstructions (19 breasts), 43 secondary reconstructions
(77 breasts), three augmentation/augmentation mastopexys
(six breasts), and five mastopexys (10 breasts) were per-
formed using TIGR Matrix Surgical Mesh. Of the 43
secondary reconstructions, 30 were reconstruction revi-
sions and 13 were augmentation/mastopexy revisions
(Table 2).
Perioperative findings included two failed ADM grafts
(two patients) as they were fragmented or not integrated at
all. Both of these patients had received prior radiation. The
biologic material implanted in their primary reconstruction
performed at different centers was found to be noninte-
grated and ineffective. The ADM grafts were thus removed
and replaced with TIGR Matrix. There were no intraop-
erative complications.
Very good cosmetic results were obtained in a variety of
breast surgery cases (Figs. 1, 2, 3 4).
The total postoperative complication rate was 20.5 % of
breasts. The total postoperative complication rate of
patients requiring an intervention was 15.2 % of breasts.
Postoperative breast complications included necrosis in
two flaps (1.8 %), two seromas (1.8 %), four infection/
extrusions (3.6 %), two relapses of inframammary fold/
malposition (1.8 %), and two with rippling (1.8 %)
(Table 3). Table 4 gives the list of operations and respec-
tive complications. All but one patient required an inter-
vention (the one with mild rippling did not need an
intervention). Another complication requiring intervention
was asymmetry in six cases (5.4 %). Grossly, the mesh was
well incorporated with deposited collagen in all patients
who had to return to the operating room (Fig. 5). Histo-
logical analysis of the incorporated TIGR Matrix showed
the mesh to still be present with surrounding fibroblasts and
collagen deposition (Fig. 6).
Nine patients had a history of radiation and thin skin
flaps resulting in a slower healing time and incorporation of
the mesh implant. These patients were also found to have
very thin skin flaps that required extra attention during the
surgical procedure. Of the nine patients who had prior
radiation, 44 % developed a postoperative complication.
One primary reconstruction patient who had radiation after
reconstruction had postoperative infection/extrusion. One
secondary reconstruction patient had prior radiation and
also experienced postoperative infection/extrusion. Two of
the primary reconstruction patients who had prior radiation
developed asymmetry that required an additional proce-
dure. Some infection complications were noted early in the
series and led to a new routine when placing the drains,
using longer subcutaneous tunnels and a longer draining
period.
Table 1 Patient characteristics
Average follow-up (months) [min-max] 16.5 [9.4–26.1]
Average age (years) 54
No. of patients with prior radiation 9 (14.5 %)
No. of smokers 4 (6.5 %)





Primary reconstruction 11 19
Reconstruction revision 30 51






Fig. 1 a Preoperative photo of patient following bilateral breast
reconstruction with bilateral scar adhesions present. b Preoperative
lateral view. c Bilateral open capsulotomies performed, TIGR mesh
support placed, silicone gel implants inserted. d Final result. e Final
result, lateral view
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Discussion
Implant-based reconstruction is a very attractive option for
women undergoing either therapeutic or prophylactic
mastectomy. Those who benefit are patients who lack
enough tissue required for autogenous reconstruction, those
that have concerns related to donor site morbidities,
patients concerned with scarring, and those that want to
have little down-time postoperatively. Immediate implant-
based reconstruction also has the particular benefit of
giving the patient an instant positive psychological
advantage. Stevens et al. [37] showed that patients who
undergo immediate reconstruction compared to patients
who have delayed reconstruction had a lower incidence of
psychological morbidity postoperatively.
Immediate breast reconstruction with expanders has
been performed using total muscle coverage of the pros-
thesis to protect the implant from exposure. It became
apparent that the rigidity of the muscle often restricted
inferior pole expansion resulting in a high-riding implant,
an ill-defined inframammary fold, and less than desirable
cosmetic results. With skin-sparing and nipple-sparing
mastectomy gaining oncologic acceptance [15, 23],
immediate implant-based reconstructions of the breast
evolved, given the benefit of having a larger skin envelope.
Despite the refinement in surgical techniques and the
introduction of new prosthetic materials, reconstruction
failure and implant dislocation are still common after
prosthetic breast reconstruction.
The use of ADM to reinforce the muscle and to provide
an increased area of coverage in the inferior pole of the
breast led to promising improvements in these recon-
structive challenges [9, 33, 35, 38]. Unfortunately, recent
literature shows an increased rate of complications asso-
ciated with the use of ADM in reconstructive breast pro-
cedures [10, 13, 17, 19, 21, 24, 40–43]. While this is
controversial because there is literature suggesting a low
complication profile with the use of ADMs, the experience
of the senior author led him to look for alternatives to
Fig. 2 a Preoperative photo of patient with right breast carcinoma.
b Insertion of temporary expander to assess submuscular pocket.
c Expander in position and TIGR mesh sutured to inferior edge of
muscle. d Immediate postoperative result. e Following expansion.
f Open capsulotomy performed prior to insertion of gel implant at
4 months; note well incorporated mesh. g Final result
Fig. 3 a Preoperative photo of patient with bilateral breast ptosis.
b Preoperative lateral view. c Following subareola mastopexy, mesh
is prepared for insertion as a hammock. d Mesh sutured into position.
e Skin closure; note elevation of breasts. f Final result. g Final result,
lateral view
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Fig. 4 a Preoperative photo of
patient following bilateral breast
reconstruction with expander
reconstruction of the right
breast. b Revision of the right
breast with insertion of TIGR
mesh support and insertion of
silicone gel breast implant.
c Mesh sutured into position.
d Closure of mesh over implant.
e Final result
Table 3 Complications






Flap necrosis 2 1.8 2
Seroma 2 1.8 2
Infection/extrusion 4 3.6 4
Relapse of IMF/malposition 2 1.8 2
Rippling 2 1.8 1
Asymmetry 11 9.8 6
Total 23 20.5 % 17 (15.2 % of total breasts)












Primary reconstruction 19 1 2 3 0 1 2
Reconstruction revision 51 0 0 1 1 1 2
Augmentation/mastopexy revision 26 0 0 0 0 0 1
Augmentation/augmentation
mastopexy
6 0 0 0 1 0 1
Mastopexy 10 1 0 0 0 0 0
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ADMs secondary to complications seen in his practice.
Some of these complications include seromas, infections,
and failure of vascularization. Brooke et al. [11] recently
showed a total complication rate in all cases in which ADM
was used of 17 % compared to 11 % in patients who did
not receive ADM during reconstruction. Infectious com-
plications were 10 % with ADM vs. 2 % without ADM. In
a large retrospective analysis by Weichman et al. [42], of
628 immediate two-stage breast reconstructions, the use of
ADM was associated with a significant increase in major
complications. Also in question are the relative mechanical
properties between individual sheets of allograft harvested
from different donors. A study out of Harvard recently
showed that there are statistically significant, highly vari-
able elastic properties between sheets of ADM harvested
from different donors [14]. This can be problematic when
symmetry is crucial in breast reconstruction.
The use of ADM in corrective reconstructive breast
surgery has also been reported in the literature [25, 26, 36].
Given the increasing evidence that ADM may be associ-
ated with increased complications, we aimed to examine
another option that could prove to be a viable alternative to
ADMs when used in select breast cases [1]. In this study
we used the TIGR Matrix Surgical Mesh. The goal of the
study was not to compare this product with ADMs or like
products but to report on its use as temporary tissue rein-
forcement in a variety of plastic surgery breast cases.
TIGR Matrix is the first long-term resorbable synthetic
mesh product. It is indicated for reinforcement of soft tis-
sue that is weak and is manufactured from two different
synthetic resorbable fibers. It has high strength during the
first 6 months following implantation and is completely
degraded and resorbed after *3 years. TIGR Matrix is
manufactured from the well-known and proven materials
glycolide, lactide, and trimethylene carbonate, which
degrade through hydrolysis and are cleared from the host
tissue through normal metabolic pathways. We are now
using it as an alternative to ADM in order to aid in cor-
rection of breast implant complications such as bottoming
out, and as an adjunct in mastopexy surgery. The knitted
structure of TIGR Matrix allows for easy handling and
fixation while being strong and flexible. As shown in pre-
clinical trials, it is rapidly vascularized, has a transient
inflammatory response, and, over time, is replaced by well-
organized connective tissue [18]. This was also our
observation during this study. In patients who had a take-
back procedure and thus whose mesh was biopsied, there
was gross and histological evidence that the mesh was
incorporating very nicely and being replaced by well-
organized connective tissue. Since its market introduction
in 2010, TIGR Matrix has been used in a variety of plastic
and general surgical procedures where soft tissue rein-
forcement is required, and it has shown excellent results
and performance with minimal complications [12].
We were pleased with the results seen in this patient
series. The decision to use the matrix was based on the
presence or absence of weakness or deficiency of tissue/
pectoralis major muscle. In cases in which complete
muscle coverage of a prosthesis was the goal, no mesh was
used if complete muscle coverage was possible. It is not
routine to use mesh in primary aesthetic procedures but it is
beneficial at times in mastopexys to hold the tissue in
position. The mesh was very easy to work with intraoper-
atively. The mesh is flexible and has excellent suture-
holding ability. We have not encountered any significant
restriction to expansion in those cases when the mesh was
used. Very good aesthetic results were obtained in a variety
of breast cases. Our total complication rate in patients
requiring a revision was 15.2 %. The complication profile
seems reasonable compared to that of ADMs. Specifically,
postoperative seroma was seen in only 1.8 % of the total
breasts reconstructed. The incidence of infections/extru-
sions was 3.6 %. These numbers are lower than those of
many published studies referenced in this article. We have
Fig. 5 TIGR mesh at 4 months. Note the fibers are well incorpo-
rated with collagen laid down over the mesh
Fig. 6 Histology at 5 months. The mesh fibers are still present
surrounded by a layer of fibroblasts and collagen
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also proven (grossly and histologically) that this mesh
incorporates very well into the patient’s native tissue. In
order for a surgical mesh to be efficacious, it must allow
vascular in-growth and incorporation into surrounding tis-
sue. This mesh certainly meets these criteria.
Based on our results, a limitation of the matrix may be
its use in severely radiated cases, as the complication rate
was 44 % in patients who had radiation therapy. Compli-
cations were more common in radiated cases, with two
infections/extrusions and two cases of asymmetry out of
the nine patients who had radiation therapy. We now do all
radiated-patient revisions in two stages, placing a Spectrum
adjustable implant initially in reconstructive cases. Pro-
longed drainage was necessary in immediate reconstruc-
tion, often up to 2 weeks.
Infection complications were noted early in this series
and led to a new routine when placing the drains, using
longer subcutaneous tunnels and a longer draining period.
These corrective actions reduced infections in the latter
half of the patient series. Other complications seen inclu-
ded loss of inframammary fold and recurrent ptosis. These
complications were seen in earlier cases where the mesh
was not adequately positioned. Persistent rippling has also
been seen in patients with very thin skin flaps. Overall, we
were very pleased with the aesthetic results achieved in this
patient series. As expected, there was a natural learning
curve to using this new product, and as the study period
went by the complication rate dropped off due to changes
in technique.
In today’s healthcare environment, cost is becoming
more important. A 10-cm 9 15-cm sheet of TIGR Matrix
costs $900. This is significantly less than the cost of ADMs
and may be one potential advantage of using this matrix
[16]. In our study, the cost of the mesh in cosmetic cases
was absorbed into the total cost of the procedure.
This study is not without its limitations. First, this is a
retrospective study. The sample size is relatively small.
While our average follow-up is 16.5 months (longest was
26.1 months), we would like to follow these patients much
longer to assess the durability of the postoperative results.
A few key surgical techniques were also changed during
the course of this study. However, we believe the change in
techniques in the latter half of the study would likely
improve the results. Also, there were no objective cosmetic
assessments performed. However, that was not in the scope
of this study. This study was not designed to be a com-
parative study between TIGR Matrix and ADMs or
between patients receiving TIGR Matrix versus no mesh.
Our goal was to prove that the TIGR Matrix could be an
alternative to ADM when extra tissue support is needed in
breast surgery cases.
The results of this study show that the synthetic long-
term resorbable mesh TIGR Matrix Surgical Mesh can be
used in patients undergoing implant-based breast recon-
struction, breast surgery revisions, or cosmetic breast pro-
cedures, and the initial data reveal that it may be a viable
alternative to acellular dermal matrices. As the product
becomes more widely used and more data become avail-
able, we believe that the TIGR Matrix may have signifi-
cant value for patients undergoing primary and secondary
implant-based breast reconstruction as well as primary
aesthetic procedures.
Conclusion
The long-term absorbable synthetic matrix TIGR Matrix
Surgical Mesh appears to have potential when used as
temporary tissue reinforcement in patients undergoing
breast reconstruction or breast surgery revision as well as
primary aesthetic procedures, and it appears to be a pos-
sible alternative for acellular dermal matrices.
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